查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1968482

脑氧饱和度监测市场－全球产业规模、份额、趋势、机会、预测：按应用、最终用户、地区和竞争对手划分，2021-2031年

Cerebral Oximetry Monitoring Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球脑氧饱和度监测市场预计将从 2025 年的 2.3068 亿美元成长到 2031 年的 3.4755 亿美元，复合年增长率为 7.07%。

这项非侵入性技术利用近红外线光光谱技术持续评估额叶皮质的局部氧饱和度，是复杂外科手术中检测和预防脑缺血的重要工具。市场成长的主要驱动因素是全球人口老化和心血管疾病负担日益加重，这导致高风险心臟和血管手术数量增加，而神经保护在这些手术中至关重要。 2024年胸腔外科协会（STS）的数据证实了这一趋势，其资料库中经导管主动脉瓣置换术术（TAVR）的数量在2022年至2018年间激增了66%。这增加了对可靠的术中监测的需求，以最大限度地降低围手术手术全期神经认知风险。

市场概览
预测期 2027-2031
市场规模：2025年 2.3068亿美元
市场规模：2031年 3.4755亿美元
复合年增长率：2026-2031年 7.07%
成长最快的细分市场 心臟外科手术
最大的市场 北美洲

然而，由于高昂的设备购置高成本和一次性感测器的持续使用费用，市场面临许多障碍。这些经济因素限制了脑氧饱和度测量技术的应用，尤其是在小规模的医疗机构和新兴经济体。在这种情况下，有限的预算往往迫使决策者优先考虑必要的治疗设备而非先进的监测系统，从而阻碍了市场扩张。

市场驱动因素

全球心血管和脑血管疾病盛行率的不断上升是推动全球脑氧饱和度监测市场发展的主要因素。随着全球心血管和脑血管疾病负担的加重，医疗系统必须更频繁地进行高风险手术，例如心臟绕道手术和血管修復，而维持脑氧合是这些手术的关键安全指标。根据美国心臟协会 (AHA) 于 2024 年 1 月发布的《2024 年心血管和中风统计更新》，2021 年全球约有 1,991 万人死于心血管疾病，这意味着大量患者可能需要接受手术治疗。因此，医院越来越重视将脑氧饱和度监测纳入手术流程，以确保病患在复杂手术中的预后。

同时，近红外线光谱技术的进步提高了设备的精度和操作性，加速了市场渗透。製造商们正在推出精密的感测器和非侵入式多参数监测主机，这些设备能够即时监测脑氧饱和度，从而推动其应用范围扩展到传统心血管手术之外。财务报告也印证了这一成长趋势。 2024年2月，爱德华生命科学公司（Edwards Life Sciences）报告称，受智慧復健技术普及的推动，其2023年第四季重症监护业务销售额增长11%，达到2.5亿美元。此外，2024年，马西莫公司（Masimo）宣布其2023年全年医疗保健收入达到12.76亿美元，进一步印证了其非侵入式监测解决方案不断扩大的财务影响力。

市场挑战

主机设备所需的大量资金投入，加上一次性感测器的持续成本，严重限制了脑氧监测系统的应用。对于预算有限的医疗机构而言，为这些设备拨出资金往往十分困难，尤其是在全身麻醉中，因为标准监测参数通常被认为足够。这种经济负担在小规模的区域医院和发展中地区尤为突出，这些地区的筹资策略优先考虑必要的治疗设备，而非专业的辅助监测技术，从而减缓了这些设备在非教学机构中的普及。

目前影响整个医疗产业的金融不稳定进一步加剧了这一经济障碍。根据美国医院协会 (AHA) 2024 年的一份报告，飙升的营运和供应成本已导致约 50% 的美国医院陷入亏损。如此微薄的营运利润迫使医院管理者实施严格的成本削减措施，导致资本设备采购经常延误。一次性感测器的持续成本进一步复杂化了预算核准流程，并直接限制了市场扩张，使其仅限于对成本敏感的医疗机构。

市场趋势

人工智慧 (AI) 和机器学习在预测分析领域的整合正在变革脑氧饱和度测量市场。这使得监测从被动的安全措施转变为主动的临床决策工具。先进的演算法现在可以分析血流动力学模式，并在脑氧饱和度下降和低血压事件发生之前进行预测，使临床医生能够主动稳定患者病情。这项技术变革正在推动显着的商业性成长，爱德华生命科学公司 2024 年 4 月发布的报告证实了这一点，该报告显示，2024 年第一季重症监护产品的销售额增长了 13%，达到 2.51 亿美元。这项绩效主要归功于人工智慧驱动的智慧恢復技术的加速应用，这些技术为临床医生提供了预测性见解。

此外，监测应用扩展到新生儿和儿童重症监护领域，呈现与传统成人心臟市场截然不同的显着成长轨迹。临床医生日益认识到脑氧饱和度测量在治疗先天性心臟疾病新生儿和早产儿的神经保护价值。维持最佳脑氧合对于预防这些患者出现长期神经发育障碍至关重要。一项发表于2024年1月《胸心血管外科年鑑》（Annals of Thoracic and Cardiovascular Surgery）的题为“优化婴儿心血管手术期间局部脑氧饱和度的效果”的研究支持了这一临床重点，该研究表明，在婴儿中实施积极的脑氧饱和度降低治疗通讯协定与术后谵妄发生率降低和手术改善显着发生率相关。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：脑氧饱和度监测的全球市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依应用领域（心臟外科、血管外科等）
    • 依最终使用者（医院/诊所、门诊手术中心、其他）划分
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美脑氧饱和度监测市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲脑氧饱和度监测市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区脑氧饱和度监测市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲脑氧饱和度监测市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲脑氧饱和度监测市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球脑氧饱和度监测市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Masimo Corp.
  • Medtronic Plc
  • Edwards Lifesciences Corporation
  • Nonin Medical Inc.
  • ISS Inc.
  • Hamamatsu Corporation
  • Mespere LifeSciences, Inc.
  • GE HealthCare Technologies, Inc.
  • Terumo Cardiovascular Systems Corporation
  • Koninklijke Philips NV

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 23871

The Global Cerebral Oximetry Monitoring Market is projected to expand from USD 230.68 Million in 2025 to USD 347.55 Million by 2031, reflecting a compound annual growth rate of 7.07%. This non-invasive technology utilizes near-infrared spectroscopy to continuously assess regional oxygen saturation in the frontal cerebral cortex, serving as a critical tool for detecting and preventing cerebral ischemia during complex surgical interventions. The market's growth is fundamentally driven by the aging global population and the increasing burden of cardiovascular diseases, which necessitate a higher volume of high-risk cardiac and vascular surgeries where neuroprotection is essential. Data from the Society of Thoracic Surgeons in 2024 highlights this trend, revealing that Transcatheter Aortic Valve Replacement procedural volumes in their database surged by 66% in 2022 compared to 2018 levels, thereby amplifying the demand for reliable intraoperative monitoring to minimize perioperative neurocognitive risks.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 230.68 Million
Market Size 2031USD 347.55 Million
CAGR 2026-20317.07%
Fastest Growing SegmentCardiac Surgery
Largest MarketNorth America

However, the market faces a significant obstacle due to the high costs associated with capital equipment and the recurring expense of disposable sensors. These financial requirements can restrict the adoption of cerebral oximetry technology, particularly within smaller healthcare facilities and emerging economies. In such settings, limited budget allocations often force decision-makers to prioritize essential therapeutic devices over advanced monitoring systems, creating a barrier to broader market expansion.

Market Driver

The rising global prevalence of cardiovascular and cerebrovascular diseases acts as a primary catalyst for the Global Cerebral Oximetry Monitoring Market. As the burden of heart and brain disorders escalates worldwide, healthcare systems are compelled to increase the frequency of high-risk interventions, such as cardiac bypasses and vascular repairs, where maintaining cerebral oxygenation is a critical safety parameter. According to the '2024 Heart Disease and Stroke Statistics Update' by the American Heart Association in January 2024, cardiovascular disease accounted for approximately 19.91 million global deaths in 2021, reflecting a massive patient pool requiring potential surgical care. Consequently, hospitals are increasingly prioritizing the integration of cerebral oximetry to safeguard patient outcomes during these complex procedures.

Simultaneously, technological advancements in near-infrared spectroscopy are enhancing market penetration by improving device precision and usability. Manufacturers are introducing refined sensors and non-invasive multi-parameter consoles that offer real-time insights into brain oxygenation, encouraging broader adoption beyond traditional cardiac surgery suites. Financial reports highlight this growth; Edwards Lifesciences reported in February 2024 that sales in their Critical Care segment grew 11% to $250 million in the fourth quarter of 2023, driven by the strong adoption of smart recovery technologies. Furthermore, Masimo reported a full-year 2023 healthcare revenue of $1.276 billion in 2024, underscoring the expanding financial footprint of non-invasive monitoring solutions.

Market Challenge

The substantial capital expenditure required for console units, combined with the recurring costs of disposable sensors, significantly restricts the adoption of cerebral oximetry monitoring systems. Healthcare institutions operating with limited budgets often find it difficult to allocate funds for these devices, particularly when standard monitoring parameters are considered sufficient for general anesthesia. This financial burden is especially pronounced in smaller community hospitals and developing regions, where procurement strategies prioritize essential therapeutic equipment over specialized adjunctive monitoring technologies, thereby slowing the penetration rate of these devices in non-academic settings.

This economic barrier is intensified by the financial instability currently affecting the broader healthcare sector. According to the American Hospital Association in 2024, approximately 50 percent of hospitals in the United States operated at a financial loss due to escalating operational expenses and supply costs. These constrained operating margins compel hospital administrators to implement strict cost-containment measures, frequently leading to the deferral of capital equipment purchases. The ongoing expense of single-use sensors further complicates budget approval processes, directly limiting the expansion of the market into cost-sensitive medical facilities.

Market Trends

The integration of Artificial Intelligence and Machine Learning for predictive analytics is transforming the cerebral oximetry market by evolving monitoring from a passive safety measure into a proactive clinical decision support tool. Advanced algorithms are now capable of analyzing hemodynamic patterns to predict cerebral desaturation and hypotensive events before they manifest, enabling clinicians to preemptively stabilize patients. This technological shift is driving substantial commercial growth, as evidenced by Edwards Lifesciences' report in April 2024, which noted a 13% increase in Critical Care segment sales to $251 million for the first quarter of 2024. This performance was primarily attributed to the accelerating adoption of their AI-enabled Smart Recovery technologies that provide predictive insights for clinicians.

Additionally, the expansion of monitoring applications into neonatal and pediatric intensive care is serving as a critical growth avenue, distinct from the traditional adult cardiac market. Clinicians are increasingly recognizing the neuroprotective value of cerebral oximetry in treating neonates with congenital heart defects and preterm infants, where maintaining optimal cerebral oxygenation is vital for preventing long-term neurodevelopmental deficits. Supporting this clinical focus, a study published in the Annals of Thoracic and Cardiovascular Surgery in January 2024, titled 'Effect of Optimizing Regional Cerebral Oxygen Saturation during Infant Cardiac Surgery', found that the implementation of aggressive cerebral desaturation treatment protocols in infants was significantly correlated with a lower incidence of postoperative delirium and improved surgical recovery.

Key Market Players

  • Masimo Corp.
  • Medtronic Plc
  • Edwards Lifesciences Corporation
  • Nonin Medical Inc.
  • ISS Inc.
  • Hamamatsu Corporation
  • Mespere LifeSciences, Inc.
  • GE HealthCare Technologies, Inc.
  • Terumo Cardiovascular Systems Corporation
  • Koninklijke Philips N.V.

Report Scope

In this report, the Global Cerebral Oximetry Monitoring Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cerebral Oximetry Monitoring Market, By Application

  • Cardiac Surgery
  • Vascular Surgery
  • Others

Cerebral Oximetry Monitoring Market, By End User

  • Hospitals & Clinics
  • Ambulatory Surgical centers
  • Others

Cerebral Oximetry Monitoring Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cerebral Oximetry Monitoring Market.

Available Customizations:

Global Cerebral Oximetry Monitoring Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cerebral Oximetry Monitoring Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Cardiac Surgery, Vascular Surgery, Others)
    • 5.2.2. By End User (Hospitals & Clinics, Ambulatory Surgical centers, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Cerebral Oximetry Monitoring Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cerebral Oximetry Monitoring Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Cerebral Oximetry Monitoring Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Cerebral Oximetry Monitoring Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application
        • 6.3.3.2.2. By End User

7. Europe Cerebral Oximetry Monitoring Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cerebral Oximetry Monitoring Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By End User
    • 7.3.2. France Cerebral Oximetry Monitoring Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Cerebral Oximetry Monitoring Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Cerebral Oximetry Monitoring Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Cerebral Oximetry Monitoring Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application
        • 7.3.5.2.2. By End User

8. Asia Pacific Cerebral Oximetry Monitoring Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Cerebral Oximetry Monitoring Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By End User
    • 8.3.2. India Cerebral Oximetry Monitoring Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Cerebral Oximetry Monitoring Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Cerebral Oximetry Monitoring Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Cerebral Oximetry Monitoring Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By End User

9. Middle East & Africa Cerebral Oximetry Monitoring Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Cerebral Oximetry Monitoring Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By End User
    • 9.3.2. UAE Cerebral Oximetry Monitoring Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By End User
    • 9.3.3. South Africa Cerebral Oximetry Monitoring Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By End User

10. South America Cerebral Oximetry Monitoring Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cerebral Oximetry Monitoring Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By End User
    • 10.3.2. Colombia Cerebral Oximetry Monitoring Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By End User
    • 10.3.3. Argentina Cerebral Oximetry Monitoring Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Cerebral Oximetry Monitoring Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Masimo Corp.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Medtronic Plc
  • 15.3. Edwards Lifesciences Corporation
  • 15.4. Nonin Medical Inc.
  • 15.5. ISS Inc.
  • 15.6. Hamamatsu Corporation
  • 15.7. Mespere LifeSciences, Inc.
  • 15.8. GE HealthCare Technologies, Inc.
  • 15.9. Terumo Cardiovascular Systems Corporation
  • 15.10. Koninklijke Philips N.V.

16. Strategic Recommendations

17. About Us & Disclaimer